• 1
    Bond GR, Campbella K, Evans LJ et al. A scale to measure quality of supported employment for persons with severe mental illness. J. Vocat. Rehabil. 2002; 17: 239250.
  • 2
    Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst. Rev. 2000; (2): CD001089.
  • 3
    Coldwell CM, Bender WS. The effectiveness of Assertive Community Treatment for homeless populations with severe mental illness: a meta-analysis. Am. J. Psychiatry 2007; 164: 393399.
  • 4
    Killaspy H, Bebbington P, Blizard R et al. The REACT study: randomised evaluation of assertive community treatment in north London. BMJ 2006; 332: 815820.
  • 5
    Sytema S, Wunderink L, Bloemers W, Roorda L, Wiersma D. Assertive community treatment in the Netherlands: a randomized controlled trial. Acta Psychiatr. Scand. 2007; 116: 105112.
  • 6
    Bonsack C, Adam L, Haefliger T, Besson J, Conus P. Difficult-to-engage patients: a specific target for time-limited assertive outreach in a Swiss setting. Can. J. Psychiatry 2005; 50: 845850.
  • 7
    Zavradashvili N, Donisi V, Grigoletti L et al. Is the implementation of assertive community treatment in a low-income country feasible? The experience of Tbilisi, Georgia. Soc. Psychiatry Psychiatr. Epidemiol. 2010; 45: 779783.
  • 8
    Lesage AD, Gelinas D, Bisson J, Dion E, Ricard N. Development and validation of the RQC: a daily contact log for ACT and ICM teams. Epidemiol. Psichiatr. Soc. 2010; 19: 4451.
  • 9
    Lohrer SP, Lukens EP, Thorning H. Economic expenditures associated with instrumental caregiving roles of adult siblings of persons with severe mental illness. Community Ment. Health J. 2007; 43: 129151.
  • 10
    Sono T, Oshima I, Ito J. Family needs and related factors in caring for a family member with mental illness: adopting assertive community treatment in Japan where family caregivers play a large role in community care. Psychiatry Clin. Neurosci. 2008; 62: 584590.
  • 11
    Teague GB, Bond GR, Drake RE. Program fidelity in assertive community treatment: development and use of a measure. Am. J. Orthopsychiatry 1998; 68: 216232.
  • 12
    Overall JER, Gorham DR. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799812.
  • 13
    Wing JK, Curtis RH, Beevor AS. HoNOS: Health of the Nation Outcome Scales: Report on Research and Development. Royal College of Psychiatrists, London, 1996.
  • 14
    Barker S, Barron N, McFarland BH, Bigelow DA. A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity. Community Ment. Health J. 1994; 30: 363383.
  • 15
    Barker S, Barron N, McFarland BH, Bigelow DA, Carnahan T. A community ability scale for chronically mentally ill consumers: Part II. Applications. Community Ment. Health J. 1994; 30: 459472.
  • 16
    The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med. 1998; 28: 551558.
  • 17
    Horvath A, Greenberg L. Development and validity of the Working Alliance Inventory. J. Couns. Psychol. 1989; 36: 223233.
  • 18
    Ruggeri M, Dall'Agnola R. The development and use of the Verona Expectations for Care Scale (VECS) and the Verona Service Satisfaction Scale (VSSS) for measuring expectations and satisfaction with community-based psychiatric services in patients, relatives and professionals. Psychol. Med. 1993; 23: 511523.
  • 19
    Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr. Bull. 1990; 16: 5767.
  • 20
    Drake RE, Wallach MA. Substance abuse among the chronic mentally ill. Hosp. Community Psychiatry 1989; 40: 10411046.
  • 21
    Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr. Res. 2000; 42: 241247.
  • 22
    Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. Examining the factor structure of the Recovery Assessment Scale. Schizophr. Bull. 2004; 30: 10351041.
  • 23
    Tessler R, Gamache G. Toolkit for Evaluating Family Experiences with Severe Mental Illness. Human Services Research Institute, Cambridge, MA, 1995.
  • 24
    Ilfeld FW. Further validation of a Psychiatric Symptom Index in a normal population. Psychol. Rep. 1976; 39: 12151228.
  • 25
    Guay J, Chabot D, Belley C, Dulude D. Principes et stratégies d'implantation de l'approche milieu. Centre de Réadaptation Normand-Laramée, Centre Jeunesse de Laval, Montreal, 2000.
  • 26
    Uher R, Maier W, Hauser J et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br. J. Psychiatry 2009; 194: 251258.
  • 27
    Rabe-Hesketh S, Skrondal A. Multilevel and Longitudinal Modeling Using Stata. Stata Press, College Station, TX, 2005.
  • 28
    Bak M, van Os J, Delespaul P et al. An observational, ‘real life’ trial of the introduction of assertive community treatment in a geographically defined area using clinical rather than service use outcome criteria. Soc. Psychiatry Psychiatr. Epidemiol. 2007; 42: 125130.
  • 29
    Kortrijk HE, Mulder CL, Roosenschoon BJ, Wiersma D. Treatment outcome in patients receiving assertive community treatment. Community Ment. Health J. 2010; 46: 330336.
  • 30
    Parker GF. Outcomes of assertive community treatment in an NGRI conditional release program. J. Am. Acad. Psychiatry Law 2004; 32: 291303.
  • 31
    Manschreck TC. Delusional disorder and shared psychotic disorder. In: Sadock BJ, Sadock VA (eds). Comprehensive Textbook of Psychiatry, 7th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2000; 12431264.
  • 32
    Angell B. Contexts of social relationship development among assertive community treatment clients. Ment. Health Serv. Res. 2003; 5: 1325.
  • 33
    Hanzawa S, Bae JK, Tanaka H et al. Caregiver burden and coping strategies for patients with schizophrenia: comparison between Japan and Korea. Psychiatry Clin. Neurosci. 2010; 64: 377386.
  • 34
    van Veldhuizen JR. FACT: a Dutch version of ACT. Community Ment. Health J. 2007; 43: 421433.